Lupin appoints Mark D McDade as Independent Director
03 February 2021 | News
McDade is the Co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health. With a career spanning over 37 years, he has led and transformed global companies as well as founded and advanced Biotech companies
Source: linkedin.com
Lupin Limited,a global pharmaceutical company, announced the appointment of Mark D McDade as an Independent Director effective January 28, 2021.
McDade is the Co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health. With a career spanning over 37 years, he has led and transformed global companies as well as founded and advanced Biotech companies.
Commenting on the appointment, Manju D Gupta, Chairman, Lupin said, “We are delighted to welcome Mark D McDade on Lupin’s board. We are confident that his diverse experience across large, mid and development-stage companies across Specialty & Biologics, will help advance our growth journey.”
McDade holds a BA in History from Dartmouth College and MBA from Harvard Business School.
